Anixa Biosciences (ANIX) announced that it, along with its partner Moffitt Cancer Center, has received approval for an amendment to the ...
Total duration of antibiotic therapy in adults hospitalized with sepsis was significantly shorter among those who received PCT-guided care vs standard care.
Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...
9d
Zacks Small Cap Research on MSNAEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol AmendmentsAEMD READ THE FULL AEMD RESEARCH REPORT Patient treatments begin in AEMD’s basket oncology trial, enrollments expected to accelerate Aethlon Medical (NASDAQ:AEMD) reported FY 3Q results yesterday and ...
CEO Jim Frakes noted that Aethlon Medical has made significant progress in focusing on oncology and implementing cost reductions. Operating expenses were reduced by 50% compared to the same quarter ...
Luckily, most streaming services these days offer a sneak peek via free trials into their cache of goodies. So whatever you’re looking to watch in 2025, these nine free trials are a great way to ...
The new Phase 2 clinical trial protocol focuses on a specific patient population (advanced, recurrent, platinum-resistant ovarian cancer patients) with limited treatment options, highlighting the ...
under the Special Protocol Assessment (SPA) process on the overall design of the Company’s planned Phase 3 AURORA trial for Descartes-08, its lead mRNA cell therapy candidate, in myasthenia ...
Jan 27 (Reuters) - Humanity Protocol has secured a fully diluted valuation of $1.1 billion after raising $20 million in a funding round co-led by Pantera Capital and Jump Crypto, the identity ...
Lata Kajania, who works as a helper at an MCD school in Delhi, busts the myth that obesity is just an urban lifestyle and a classist concern. Or that an existing weight metric is enough to tell you ...
A 33-year-old man, Nagesh, died while participating in a Bengaluru-based clinical trial by Syngene International Limited. Nagesh developed complications after receiving an injection and a tablet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results